CollPlant Biotechnologies Ltd.

NasdaqGM:CLGN 株式レポート

時価総額:US$55.8m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

CollPlant Biotechnologies 将来の成長

Future 基準チェック /56

CollPlant Biotechnologiesは、61.1%と30.3%でそれぞれ年率61.1%で利益と収益が成長すると予測される一方、EPSはgrowで59.7%年率。

主要情報

61.1%

収益成長率

59.7%

EPS成長率

Biotechs 収益成長24.5%
収益成長率30.3%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日30 May 2024

今後の成長に関する最新情報

Recent updates

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Feb 03
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

Nov 02
Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Sep 06
CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Jul 14
Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

Nov 10
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

CollPlant Non-GAAP EPS of -$0.36, revenue of $0.07M

Aug 25

We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

Jul 22
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 22
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company

Aug 05

Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Jul 29
Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

Jun 09
The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

業績と収益の成長予測

NasdaqGM:CLGN - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026220N/AN/A1
12/31/202515-6N/AN/A1
12/31/20243-17N/AN/A1
3/31/202411-7-3-3N/A
12/31/202311-7-4-3N/A
9/30/202311-7-5-4N/A
6/30/202311-7-15-14N/A
3/31/20231-17-15-14N/A
12/31/20220-17-15-14N/A
9/30/20221-16-14-13N/A
6/30/20221-15-14-12N/A
3/31/20221-14-14-12N/A
12/31/202116013N/A
9/30/202116123N/A
6/30/202120578N/A
3/31/202120699N/A
12/31/20206-6-5-4N/A
9/30/20206-7-5-4N/A
6/30/20203-11-8-7N/A
3/31/20202-11-8-7N/A
12/31/20192-11-7-6N/A
9/30/20196-6-2-1N/A
6/30/20196-6-2-1N/A
3/31/20195-4-2-1N/A
12/31/20185-6-2-1N/A
9/30/20181-6-7-6N/A
6/30/20181-6-6-6N/A
3/31/20181-7-5-5N/A
12/31/20170-6N/A-5N/A
9/30/20170-6N/A-5N/A
6/30/20170-7N/A-5N/A
3/31/20170-7N/A-5N/A
12/31/20160-7N/A-5N/A
9/30/20160-7N/A-5N/A
6/30/2016N/A-7N/A-5N/A
3/31/2016N/A-6N/A-5N/A
12/31/2015N/A-5N/A-4N/A
9/30/2015N/A-4N/A-4N/A
6/30/2015N/A-4N/A-4N/A
3/31/2015N/A-3N/A-3N/A
12/31/2014N/A-3N/A-3N/A
9/30/2014N/A-4N/A-4N/A
6/30/2014N/A-4N/A-4N/A
3/31/2014N/A-4N/A-4N/A
12/31/2013N/A-5N/A-4N/A
9/30/2013N/A-5N/A-3N/A

アナリストによる今後の成長予測

収入対貯蓄率: CLGNは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: CLGN今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: CLGN今後 3 年以内に収益を上げることが予想されます。

収益対市場: CLGNの収益 ( 30.3% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: CLGNの収益 ( 30.3% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: CLGNの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘